These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 9760762)

  • 1. [Evidence of new diagnostic and prognostic human astrocytoma tumor markers. Potential therapeutic applications. II].
    Kiss R
    Bull Mem Acad R Med Belg; 1998; 153(3):209-20; discussion 220-1. PubMed ID: 9760762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of gastrin and/or cholecystokinin antagonists on the proliferation of three human astrocytic tumor cell lines.
    Camby I; Salmon I; Oiry C; Galleyrand JC; Nagy N; Danguy A; Brotchi J; Pasteels JL; Martinez J; Kiss R
    Neuropeptides; 1996 Oct; 30(5):433-7. PubMed ID: 8923504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant astrocytic glioma: genetics, biology, and paths to treatment.
    Furnari FB; Fenton T; Bachoo RM; Mukasa A; Stommel JM; Stegh A; Hahn WC; Ligon KL; Louis DN; Brennan C; Chin L; DePinho RA; Cavenee WK
    Genes Dev; 2007 Nov; 21(21):2683-710. PubMed ID: 17974913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo.
    de Groot JF; Liu TJ; Fuller G; Yung WK
    Cancer Res; 2005 Mar; 65(5):1934-40. PubMed ID: 15753393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
    Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
    Hoelzinger DB; Demuth T; Berens ME
    J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
    Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
    Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor differentially regulates low density lipoprotein receptor-related protein gene expression in neoplastic and fetal human astrocytes.
    Hussaini IM; Brown MD; Karns LR; Carpenter J; Redpath GT; Gonias SL; Vandenberg SR
    Glia; 1999 Jan; 25(1):71-84. PubMed ID: 9888299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
    Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
    Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
    Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
    Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of prognostic markers in brain tumors.
    Grzybicki DM; Moore SA
    Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contactin is expressed in human astrocytic gliomas and mediates repulsive effects.
    Eckerich C; Zapf S; Ulbricht U; Müller S; Fillbrandt R; Westphal M; Lamszus K
    Glia; 2006 Jan; 53(1):1-12. PubMed ID: 16078236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural and cancer stem cells in tumor suppressor mouse models of malignant astrocytoma.
    Llaguno SA; Chen J; Kwon CH; Parada LF
    Cold Spring Harb Symp Quant Biol; 2008; 73():421-6. PubMed ID: 19022744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.
    Pisati F; Belicchi M; Acerbi F; Marchesi C; Giussani C; Gavina M; Javerzat S; Hagedorn M; Carrabba G; Lucini V; Gaini SM; Bresolin N; Bello L; Bikfalvi A; Torrente Y
    Cancer Res; 2007 Apr; 67(7):3054-63. PubMed ID: 17409412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
    Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
    Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
    Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.